Two recently discovered genetic differences between brain cancer cells and normal tissue cells -- an altered gene and a snippet of noncoding genetic material -- could offer clues to tumor behavior and potential new targets for therapy, Johns Hopkins scientists report.
Changes in the epigenetics suggest a prognostic marker for childhood ependymomas and similarities with DIPG tumors, report scientists.
A multi-institutional group of researchers, led by investigators at Children's Hospital Los Angeles and the University of Michigan, have identified a simple and inexpensive tool for assessing the prognosis of pediatric brain tumors called ependymomas.
A woman had a cold virus injected into her brain tumor in an effort to eradicate it, making her the first person in the United States to participate in a clinical trial using this method, which incorporates immunotherapy, and was performed by doctors at the University of Arkansas for Medical Sciences (UAMS).
As computers get ever brainier, they're disrupting everything from web search to diagnosing brain tumors
Study Highlights Designed a smart drug that only targets and kills cancer cells. Validated a compound that sensitizes tumors to chemotherapy and results in a significant extension of life in an animal model.
Holiday had missed the season to be with his wife, who had surgery to remove a brain tumor
(Uppsala University) Children that are diagnosed with the severe the brain tumor malignant glioma often have a very poor prognosis. New findings from Uppsala University show that in mice glioma development and glioma cell properties are affected by both age and the cell type from which the tumor has arisen. Show More Summary
Children that are diagnosed with the severe the brain tumor malignant glioma often have a very poor prognosis. Knowledge about how pediatric malignant glioma arises and develops is still limited. New findings show that in mice glioma development and glioma cell properties are affected by both age and the cell type from which the tumor has arisen. Show More Summary
An experimental cancer imaging tool that makes tumors glow brightly during surgery has shown promise again in a new clinical study, this time in patients with brain cancer. The fluorescent dye technique, originally developed by surgeons to treat lung cancer, illuminated brain tumors in real-time during surgery, helping physicians distinguish between healthy and cancerous tissue
(University of Pennsylvania School of Medicine) An experimental cancer imaging tool that makes tumors glow brightly during surgery has shown promise again in a new Penn Medicine clinical study, this time in patients with brain cancer. Show More Summary
The New Orleans Pelicans point guard who took a leave of absence to care for his newborn baby girl and help his wife recover from brain surgery will return to the court on Friday, the team’s general manager announced on Tuesday. Pelicans GM Dell Demps says Jrue Holiday will return to game action Friday vs […]
(University of Hawaii Cancer Center) University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age. The discovery can help researchers create novel targeted therapies potentially reducing deaths from this devastating cancer.
David Parnes may not have believed in the price that his partner, James Harris, set for a home on this week’s episode of Million Dollar Listing Los Angeles, but the two of them decided to push the contractors and a deal was made. But on a personal level, Parnes was going through some troubling times,... Show More Summary
Holiday has been taking care of his wife, former U.S. Soccer star Lauren Holiday, as she recovers from a brain tumor. New Orleans Pelicans' point guard Jrue Holiday's return to the court is "imminent," according to The Vertical's Adrian Wojnarowski. Show More Summary
After missing the first nine games of the season to care for his wife, New Orleans Pelicans guard Jrue Holiday will reportedly return to the court imminently. According to Adrian Wojnarowski of The Vertical, Holiday is expected to make his season debut next week. Show More Summary
A routine test can be used to identify which patients may require intensive clinical management and surveillance for aggressive brain tumors, new findings suggest.
(Brigham and Women's Hospital) Researchers from Brigham and Women's Hospital, in collaboration with colleagues at Massachusetts General Hospital, have identified genetic mutations that can distinguish aggressive rhabdoid meningiomas from more benign forms using routine laboratory tests.
A signaling pathway has the potential to block a type of cancer in the cerebellum, suggests new research. The work is focused on brain tumor formation in animal models of medulloblastoma, the most common malignant brain tumor diagnosed in children.
(Cancer Research UK) Characteristics like seizures, location of the tumour, and pressure in the brain, give insight into length of survival and treatment options for brain tumour patients over the age of 70, according to new research presented at the National Cancer Research Institute's (NCRI) Cancer Conference in Liverpool.